Market Capitalization (Millions $) |
1,196 |
Shares
Outstanding (Millions) |
132 |
Employees |
- |
Revenues (TTM) (Millions $) |
76 |
Net Income (TTM) (Millions $) |
-69 |
Cash Flow (TTM) (Millions $) |
-38 |
Capital Exp. (TTM) (Millions $) |
25 |
Cti Biopharma Corp
CTI Biopharma Corp is a biopharmaceutical company that focuses on the development and commercialization of targeted therapies for blood-related cancers. The company is engaged in researching treatments for these types of cancers, including myeloproliferative neoplasms and leukemia. CTI Biopharma Corp's pipeline includes investigational drugs that aim to address unmet medical needs in these areas. The company is dedicated to improving the lives of cancer patients through innovative therapies and advancing scientific knowledge in the field of oncology.
Company Address: 3101 Western Avenue Seattle 98121 WA
Company Phone Number: 282-7100 Stock Exchange / Ticker: NASDAQ CTIC
|